Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasized mammary carcinoma;Verbrauchskoagulopathie und Hyperfibrinolyse bei Hunden mit metastasierendem Mammakarzinom

Schweizer Archiv fur Tierheilkunde

Volumn 140, Issue 12, 1998, Pages 497-504

  Mischke, Reinhard ^a   Wohlsein, P ^a   Busse, L ^a   Pohlenz, J ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Dog; Fibrin(ogen) degradation products; Haemostatic potential; Metastasized mammary carcinoma; Soluble fibrin

Indexed keywords

CANIS FAMILIARIS;

FIBRIN; FIBRIN DEGRADATION PRODUCT;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DISSEMINATED INTRAVASCULAR CLOTTING; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FIBRINOLYSIS; LYMPH NODE METASTASIS; METASTASIS; PATHOLOGY; VASCULAR TUMOR;

ANIMALS; DISSEMINATED INTRAVASCULAR COAGULATION; DOG DISEASES; DOGS; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, ANIMAL; VASCULAR NEOPLASMS;

EID: 0032247928     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Callander N S., Varki N., Mohan Rao L. V. (1992) Immunohibtochemical identification of tissue factor in solid tumors Cancer 70. 1194-1201
2. Clauss (1957): Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens.Acta Haematol. 17, 237-246
3. Donati M.B., Vermylen J., Verstraete M (1971) Fibrinogen degradation products and a fibrinogen assay based on clotting kinetics Scand J. Haematol 8, Suppl 13, 255-256.
4. Dvorak H.M (1986). Tumors wounds that do not heal. N. Engl J. Med 315, 1650-1659
5. Eckersall P.D., Conner J.G (1988) Bovine and canine acute phase proteins. Vet Res Commun. 12, 169-178
6. Gordon S.G, Cross B.A (1981) A factor X-activating cysteine protease from malignant tissue J. Clin. Invest. 67, 1665-1671.
7. Griffin J H., Mosher D.F., Zimmermann T.S., Kleiss A J. (1982): Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation Blood 60, 261-264
8. Gunji Y., Lewis J., Gorelik E. (1990). Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells Blood Coagul. Fibrinol. 1, 663-672
9. Hardaway R M., Johnson D G., Elovitz M.J., Houchin D.N., Jenkins E.B., Burns J.W. Jackson D.R. (1964) Studies on the fibrinogen replacement rate in dogs Ann Surg. 160, 835-838.
10. Hagiwara M K., Kogika M. M., Malucelli B E (1990) Disseminated intravascular coagulation in dogs with aflatoxicosis J. Small Anim Pract 31, 239-243
11. Hartert H (1981): Resonance-thrombography theoretical and practical elements Biorheology 18, 693-701
12. Hoffman M., Greenberg C S. (1987) 'The effect of fibrin polymerisation inhibitors on quantitative measurements of plasma fibrinogen. Am J. Clin. Pathol. 88, 490-493
13. Jacobsson K (1955) Studies on fibrinogcn: I. Studies on determination of fibrinogen in human blood plasma Scand J. Clin. Lab. Invest 7, 1-54.
14. Lees G.E., Leighton R. L., Hart R (1977): Management of gastric dilatation-volvulus and disseminated intravascular coagulation in a dog. a case report J.Am Anim. Hosp Assoc. 13, 463-469.
15. Marlar R. A., Kleiss A J., Griffin J.H (1982): Mechanism of action of human activated protein C. a thrombin-dependent anticoagulant enzyme Blood 59, 1067-1072.
16. McNicol G P., Davies J.A. (1973): Fibrinolytic enzyme system Clin Hematol 2, 23-51
17. Mischke R. (1995): Evaluation of a prothrombin time optimized for the dog on plasmas with defined coagulation factor activity due to coumarin intoxication. J. Vet. Med.A 42, 589-599
18. Mischke R (1997): Überprüfung der Aussagekraft und Optimierung von Methoden zur Untersuchung des Hämostasesystems des Hundes. Tierarztl Hochsch Hannover, Habil. - Schrift.
19. Mischke K., Nolte I. (1997): Optimization of prothrombin time - measurements in canine plasma.Am J Vet Res 58, 236-241
20. Nakama S., Tanaky M., Goto N., Komatsu T (1985): A case report of canine disseminated intravascular coagulation (DIC) Jpn. J.Vet Sci 47, 329-332.
21. O'Grady P., Lijnen H.R., Duffy M J. (1985) Multiple forms of plasminogen activator in human breast tumors. Cancer Res. 45, 6216-6221
22. Okajima K., Kohno I., Tsuruta J., Okabe H., Takatsuki K . Binder B R. (1992). Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer.Thromb Res 66, 717-727.
23. Schalm O.W (1980): Disseminated intravascular coagulation (DIG) in the dog.Canine Pract 7, 52-54.
24. Slappendel R.J., De Maat C.E.M., Rijnberk A., Van Arkel C. (1970): Spontaneous consumption coagulopathy in a dog with thyroid cancer. Thromb.Diathes Haemorrh. 24, 129-135
25. Slappendel R J., Van Arkel C., Mieog W.H.W., Bouma B.N. (1972) Response to heparin of spontaneous disseminated intravascular coagulation Zentralbl.Vet Med A 19, 502-513.
26. Spannagl M., Schramm W (1987): Klinische Erprobung eines kinetischen Trubungstestes zur Fibrinogenbestimmung. Lab. med. 11, 123-127.
27. Stockhaus C., Kohn B., Rudolph R., Giger U., Brunnberg I. (1997) Gerinnungsstorungen beim Mammakarzinom des Hundes In 6 Jahrestagung der Fachgruppe «Innere Medizin und Klinische Laboratoriumsdiagnostik» der Deutschen Veterinärmedizinischen Gesellschaft. München, 5 -9-März 1997. Zusammenfassung der Vorträge, DVG-Selbstverlag, Gießen, S. 144 (Abstr).